Streetbeat News

Revenues

OGI

OrganiGram Holdings (NASDAQ:OGI) reported Q4 sales of $34.33M, surpassing the $29.52M estimate by 16.29%, but saw a 1.54% decrease from the $34.87M in the same period last year. The company also reported a net loss of $24.59M.

Portfolio Pulse from Benzinga Newsdesk

December 19, 2023 | 11:08 am

OPT

Opthea, a biotech company, has received an R&D tax credit of A$8.8 million (approximately $5.9 million) from the Australian Taxation Office. This financial boost acknowledges the company's research and development efforts.

Portfolio Pulse from Benzinga Newsdesk

December 19, 2023 | 11:02 am

VGK

Eurozone CPI for November showed a month-on-month decrease of 0.6%, which is in line with estimates. The year-on-year inflation rate is 2.4%, also matching expectations.

Portfolio Pulse from Charles Gross

December 19, 2023 | 10:02 am

TSLA

Tesla, Inc. (TSLA) faces challenges in Germany as the government ends an environmental bonus, impacting electric vehicle subsidies. Tesla's Giga Berlin plant is reported to shut down from Dec. 22 to Jan. 2, 2024, potentially affecting the company's annual production target. In response to the subsidy cut, Tesla offers compensation for new Model 3/Y orders. Analyst Gordon Johnson questions Tesla's demand without government subsidies, implying overcapacity. Tesla's stock dropped slightly following the news.

Portfolio Pulse from Shanthi Rexaline

December 19, 2023 | 9:13 am

RHHBY

Roche's navify digital solutions, including navify Tumor Board, navify POC Operations, and navify Lab Operations, have received excellent ratings from healthcare professionals according to KLAS Research. The solutions are praised for improving tumor board meetings, enhancing point-of-care device management, and automating lab processes, with 100% of professionals indicating they would repurchase.

Portfolio Pulse from Benzinga Newsdesk

December 19, 2023 | 7:06 am

AAPL

MASI

Apple Inc. (AAPL) is facing a potential U.S. ban on its smartwatch products, which could impact its $17 billion smartwatch business. The International Trade Commission is set to enforce the ban on Dec. 25 over a patent infringement claim by Masimo Corp. (MASI) regarding blood oxygen level monitoring technology. Apple is attempting to modify the technology to comply with the ban and has begun preparing its stores for the change, including halting sales of certain models. Masimo insists that a software fix is not enough and hardware changes are necessary. The ban could significantly affect Apple's revenue and highlights the legal complexities in the tech industry.

Portfolio Pulse from Ananya Gairola

December 19, 2023 | 1:47 am

SVT

Servotronics anticipates revenue growth for FY24 to be at or above industry growth rates, with gross margins nearing levels seen before the pandemic.

Portfolio Pulse from Benzinga Newsdesk

December 18, 2023 | 11:02 pm

FMC

FMC Corporation has started a global restructuring plan named 'Project Focus' in reaction to a significant downturn in the global crop protection market, which has led to severe channel destocking, according to a recent filing.

Portfolio Pulse from Benzinga Newsdesk

December 18, 2023 | 9:38 pm

HEI

Heico Corporation reported a Q4 2023 EPS of $0.74, up from $0.70 year-over-year, and revenue of $936.4M, surpassing the estimate of $898.248M.

Portfolio Pulse from Benzinga Newsdesk

December 18, 2023 | 9:32 pm

NWGL

Nature Wood Group Limited reported a significant decline in total revenue for the first half of the year, with a 49.6% decrease to $15.6 million compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

December 18, 2023 | 9:31 pm